Reni J. Benjamin Stock Analyst Profile - JMP Securities Research Coverage - Stocknear

Reni J. Benjamin

Stock Analyst at JMP Securities

(4.67)
# 1363
Out of 5,506 analysts
8
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

7 Stocks

Name Action PT Current % Upside Ratings Updated
SMMT Summit Therapeutics
Reiterates: Market Outperform
40 40
21.43 86.65% 2 Sep 3, 2025
INBX Inhibrx Biosciences
Reiterates: Market Perform
n/a
n/a n/a 1 Aug 22, 2025
HOWL Werewolf Therapeutic...
Maintains: Market Outperform
4 3
2.05 46.34% 1 Aug 21, 2025
PRLD Prelude Therapeutics
Maintains: Market Outperform
4 3
1.47 104.08% 1 Aug 18, 2025
BCAB BioAtla
Downgrades: Market Perform
n/a
n/a n/a 1 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
22 10
8.37 19.47% 1 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Outperform
28 24
9.57 150.78% 1 Aug 11, 2025